Table 2 Baseline characteristics and outcome of matched adults
From: Impact of tight glucose control on circulating 3-hydroxybutyrate in critically ill patients
Baseline characteristics | Liberal GC (N = 50) | Tight GC (N = 50) | P Value |
|---|---|---|---|
Age (years)—median (IQR) | 65 (56–74) | 66 (55–74) | 0.73 |
Length (cm)—median (IQR) | 170 (165–176) | 172 (170–179) | 0.27 |
BMI (kg/m2)—median (IQR) | 24.2 (21.6–27.7) | 24.8 (22.0–27.5) | 0.53 |
Sex (male)—no. (%) | 41 (82) | 45 (90) | 0.39 |
Diagnostic group—no. (%) | 0.93 | ||
Surgical | |||
Transplantation—no. (%) | 4 (8) | 2 (4) | |
Cardiac surgery—no. (%) | 17 (34) | 19 (38) | |
Other surgery—no. (%) | 9 (18) | 9 (18) | |
Medical—no. (%) | 20 (40) | 20 (40) | |
History of malignancy—no. (%) | 6 (12) | 6 (12) | 1.00 |
APACHE-II score—median (IQR) | 12 (8–19) | 12 (8–21) | 0.93 |
Outcome | |||
|---|---|---|---|
ICU mortality—no. (%) | 16 (32) | 5 (10) | 0.01 |
Length of ICU stay (days)—median (IQR) | 8 (4–18) | 6 (4–14) | 0.33 |